{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-1978-N-0018\" and posted_year = 2019 sorted by posted_date descending", "rows": [["FDA-1978-N-0018-15807", "FDA", "FDA-1978-N-0018", "PCPC Meeting - Second Announcement of Meeting Postponement", "Other", "Briefing Schedule", "2019-11-15T05:00:00Z", 2019, 11, "2019-11-15T05:00:00Z", null, "2019-11-15T18:49:06Z", null, 0, 0, "09000064841640a8"], ["FDA-1978-N-0018-15806", "FDA", "FDA-1978-N-0018", "PCPC Meeting -Announcement of Meeting Postponement", "Other", "Briefing Schedule", "2019-11-13T05:00:00Z", 2019, 11, "2019-11-13T05:00:00Z", null, "2019-11-15T18:48:48Z", null, 0, 0, "090000648414f983"], ["FDA-1978-N-0018-15805", "FDA", "FDA-1978-N-0018", "Preliminary Comments from FDA to PCPC Public Meeting Sunscreen Ingredient Deferral Work Plan", "Other", "Briefing Schedule", "2019-11-12T05:00:00Z", 2019, 11, "2019-11-12T05:00:00Z", null, "2019-11-12T15:30:09Z", null, 0, 0, "0900006484145bca"], ["FDA-1978-N-0018-15804", "FDA", "FDA-1978-N-0018", "Briefing Documents for PCPC Meeting Request", "Other", "Briefing Schedule", "2019-11-08T05:00:00Z", 2019, 11, "2019-11-08T05:00:00Z", null, "2019-12-11T17:20:40Z", null, 0, 0, "09000064841307a4"], ["FDA-1978-N-0018-15803", "FDA", "FDA-1978-N-0018", "Request for Meeting from EMD Performance Materials to FDA CDER", "Other", "Request", "2019-10-29T04:00:00Z", 2019, 10, "2019-10-29T04:00:00Z", null, "2019-10-29T16:02:52Z", null, 0, 0, "09000064841057cb"], ["FDA-1978-N-0018-15802", "FDA", "FDA-1978-N-0018", "Response Letter from FDA CDER to Personal Care Product Council", "Other", "Letter(s)", "2019-10-29T04:00:00Z", 2019, 10, "2019-10-29T04:00:00Z", null, "2019-10-29T12:23:13Z", null, 0, 0, "0900006484101886"], ["FDA-1978-N-0018-15800", "FDA", "FDA-1978-N-0018", "Meeting Request from Personal Care Products Council", "Other", "Request", "2019-09-17T04:00:00Z", 2019, 9, null, null, "2019-09-17T19:25:29Z", null, 0, 0, "0900006483f8fa27"], ["FDA-1978-N-0018-15798", "FDA", "FDA-1978-N-0018", "PCRM Meeting Request", "Other", "Request", "2019-08-28T04:00:00Z", 2019, 8, "2019-08-28T04:00:00Z", null, "2019-08-28T18:12:09Z", null, 0, 0, "0900006483ed5158"], ["FDA-1978-N-0018-15799", "FDA", "FDA-1978-N-0018", "Physician Committee for Responsible Medicine Meeting Request Denied", "Other", "Denial", "2019-08-28T04:00:00Z", 2019, 8, "2019-08-28T04:00:00Z", null, "2019-08-28T18:15:14Z", null, 0, 0, "0900006483ed4f17"], ["FDA-1978-N-0018-15797", "FDA", "FDA-1978-N-0018", "Response Letter from FDA/CDER to Cosmetic Toiletry and Fragrance Association of South Africa and Dershana Valla", "Other", "Response(s)", "2019-08-27T04:00:00Z", 2019, 8, "2019-08-27T04:00:00Z", null, "2019-08-27T14:23:26Z", null, 0, 0, "0900006483ecd1b7"], ["FDA-1978-N-0018-15795", "FDA", "FDA-1978-N-0018", "Extension Request for Extension from Personal Care Products Council (PCPC) and Consumer Healthcare Products Association (CHPA)", "Other", "Request for Extension", "2019-08-26T04:00:00Z", 2019, 8, "2019-08-26T04:00:00Z", null, "2019-08-26T18:47:06Z", null, 0, 0, "0900006483ec23d0"], ["FDA-1978-N-0018-15796", "FDA", "FDA-1978-N-0018", "Extension from FDA/CDER to PCPC and CHPA", "Other", "Letter(s)", "2019-08-26T04:00:00Z", 2019, 8, "2019-08-26T04:00:00Z", null, "2019-08-26T18:52:57Z", null, 0, 0, "0900006483ec23fd"], ["FDA-1978-N-0018-15793", "FDA", "FDA-1978-N-0018", "FDA Response Letter to CHPA and PCPC Request for Deferral of Eight Sunscreen Ingredients", "Other", "Response(s)", "2019-07-29T04:00:00Z", 2019, 7, "2019-07-29T04:00:00Z", null, "2019-07-29T15:56:16Z", null, 0, 0, "0900006483dc652c"], ["FDA-1978-N-0018-2417", "FDA", "FDA-1978-N-0018", "Meeting Minutes with PASS Coalition", "Other", "Minutes", "2019-06-28T04:00:00Z", 2019, 6, "2019-06-28T04:00:00Z", null, "2019-06-28T14:15:59Z", null, 0, 0, "0900006483d4b9ff"], ["FDA-1978-N-0018-2416", "FDA", "FDA-1978-N-0018", "Agency Response Letter from FDA CDER to John G. Moore", "Other", "Letter(s)", "2019-06-27T04:00:00Z", 2019, 6, "2019-06-27T04:00:00Z", null, "2019-06-27T21:11:09Z", null, 0, 0, "0900006483d496f0"], ["FDA-1978-N-0018-2133", "FDA", "FDA-1978-N-0018", "Meeting Minutes with Personal Care Product Council", "Other", "Minutes", "2019-06-21T04:00:00Z", 2019, 6, "2019-06-21T04:00:00Z", null, "2019-06-21T16:24:51Z", null, 0, 0, "0900006483d32193"], ["FDA-1978-N-0018-2134", "FDA", "FDA-1978-N-0018", "Meeting Minutes with PASS Coalition", "Other", null, "2019-06-21T00:00:00Z", 2019, 6, null, null, "2019-06-28T11:34:44Z", null, 0, 1, "0900006483d32194"], ["FDA-1978-N-0018-2060", "FDA", "FDA-1978-N-0018", "Minutes of Meeting with American Academy of Dermatology Association", "Other", "Minutes", "2019-05-23T04:00:00Z", 2019, 5, "2019-05-23T04:00:00Z", null, "2019-05-23T19:24:12Z", null, 0, 0, "0900006483cc2376"], ["FDA-1978-N-0018-1649", "FDA", "FDA-1978-N-0018", "Sunscreen Drug Products for Over-the-Counter Human Use; Correction", "Proposed Rule", "Correction", "2019-04-18T04:00:00Z", 2019, 4, "2019-04-18T04:00:00Z", "2019-06-28T03:59:59Z", "2024-04-16T20:27:21Z", "2019-07712", 0, 0, "0900006483bb94cb"], ["FDA-1978-N-0018-1648", "FDA", "FDA-1978-N-0018", "Sunscreen Drug Products for Over-the-Counter Human Use; Extension of\nComment Period", "Proposed Rule", "Extension of Comment Period", "2019-04-18T04:00:00Z", 2019, 4, "2019-04-18T04:00:00Z", "2019-06-28T03:59:59Z", "2019-09-24T01:03:41Z", "2019-07710", 0, 0, "0900006483bb93d6"], ["FDA-1978-N-0018-1066", "FDA", "FDA-1978-N-0018", "Request for Extension from Personal Care Products Council and Consumer Healthcare Products Association", "Other", "Request for Extension", "2019-03-05T05:00:00Z", 2019, 3, "2019-03-05T05:00:00Z", null, "2019-03-05T15:03:57Z", null, 0, 0, "0900006483abcb19"], ["FDA-1978-N-0018-1065", "FDA", "FDA-1978-N-0018", "Reference 63 - FDA Preliminary Regulatory Impact Analysis", "Supporting & Related Material", "Background Material", "2019-03-01T05:00:00Z", 2019, 3, null, null, "2019-03-01T17:49:33Z", null, 0, 0, "0900006483ab64ac"], ["FDA-1978-N-0018-1055", "FDA", "FDA-1978-N-0018", "Reference 44 - Hong_2014_Effect of zinc oxide nanoparticles on dams and embryo\u2013fetal development in rats", "Supporting & Related Material", "Background Material", "2019-03-01T05:00:00Z", 2019, 3, null, null, "2019-03-01T13:43:06Z", null, 0, 0, "09000064839b2eff"], ["FDA-1978-N-0018-1049", "FDA", "FDA-1978-N-0018", "Reference 208 - Kasichayanula_2005_Simultaneous Analysis of Insect Repellent DEET, Sunscreen Oxybenzone and Five Relevant Metabolites", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:47:51Z", null, 0, 0, "09000064839b30e1"], ["FDA-1978-N-0018-1034", "FDA", "FDA-1978-N-0018", "Reference 193 - Katz_2008_Insect Repellants- Historical Perspectives and New Developments", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:26:28Z", null, 0, 0, "09000064839b30ad"], ["FDA-1978-N-0018-1037", "FDA", "FDA-1978-N-0018", "Reference 196 - FDA_Food Additive Status List", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:28:57Z", null, 0, 0, "09000064839b30b0"], ["FDA-1978-N-0018-1031", "FDA", "FDA-1978-N-0018", "Reference 190 - EPA_Using Insect Repellents Safely and Effectively", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:23:32Z", null, 0, 0, "09000064839b30aa"], ["FDA-1978-N-0018-1051", "FDA", "FDA-1978-N-0018", "Reference 210 - Yiin_2015_Assessment of Dermal Absorption of DEET-Containing Insect Repellent and Oxybenzone-Containing Sunscreen", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:51:08Z", null, 0, 0, "09000064839b30e3"], ["FDA-1978-N-0018-1032", "FDA", "FDA-1978-N-0018", "Reference 191 - AAP_Choosing an Insect Repellent for Your Child - Tips for Using Repellents Safely", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:24:41Z", null, 0, 0, "09000064839b30ab"], ["FDA-1978-N-0018-1038", "FDA", "FDA-1978-N-0018", "Reference 197 - EPA_RED Facts_Oil of Citronella", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:29:45Z", null, 0, 0, "09000064839b30b1"], ["FDA-1978-N-0018-1035", "FDA", "FDA-1978-N-0018", "Reference 194 - EPA_Technical document IR3535", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:27:15Z", null, 0, 0, "09000064839b30ae"], ["FDA-1978-N-0018-1045", "FDA", "FDA-1978-N-0018", "Reference 204 - Girschik_2008_Deaths from non-melanoma skin cancer in western Australia", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:39:48Z", null, 0, 0, "09000064839b30dd"], ["FDA-1978-N-0018-1048", "FDA", "FDA-1978-N-0018", "Reference 207 - Wang_2007_In vitro percutaneous permeation of the repellant DEET and the sunscreen oxybenzone across human skin", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:47:01Z", null, 0, 0, "09000064839b30e0"], ["FDA-1978-N-0018-1052", "FDA", "FDA-1978-N-0018", "Reference 211 - Montemarano_1997_Insect repellents and the efficacy of sunscreens", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:52:17Z", null, 0, 0, "09000064839b30e4"], ["FDA-1978-N-0018-1047", "FDA", "FDA-1978-N-0018", "Reference 206 - Gu_2005_In Vitro Evaluation of Concurrent Use of Commercially Available Insect Repellent and Sunscreen Preparations", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:43:25Z", null, 0, 0, "09000064839b30df"], ["FDA-1978-N-0018-1030", "FDA", "FDA-1978-N-0018", "Reference 189 - EPA_Active ingredients eligible for minimum risk pesticide products", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:22:49Z", null, 0, 0, "09000064839b3020"], ["FDA-1978-N-0018-1050", "FDA", "FDA-1978-N-0018", "Reference 209 - Kasichayanula_2007_Percutaneous Characterization of the Insect Repellent DEET and the Sunscreen Oxybenzone", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:48:42Z", null, 0, 0, "09000064839b30e2"], ["FDA-1978-N-0018-1041", "FDA", "FDA-1978-N-0018", "Reference 200 - CDC_Protection against Mosquitoes, Ticks, & Other Arthropods", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:33:00Z", null, 0, 0, "09000064839b32d7"], ["FDA-1978-N-0018-1053", "FDA", "FDA-1978-N-0018", "Letter from FDA CDER to L'Oreal USA Product", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T17:58:01Z", null, 0, 0, "0900006483ab204f"], ["FDA-1978-N-0018-1042", "FDA", "FDA-1978-N-0018", "Reference 201 - AAP_Choosing an Insect Repellent for Your Child - Tips for Using Repellents Safely", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:37:43Z", null, 0, 0, "09000064839b32d8"], ["FDA-1978-N-0018-1039", "FDA", "FDA-1978-N-0018", "Reference 198 - NPIC_Oil of Citronella Fact Sheet", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:31:14Z", null, 0, 0, "09000064839b30b2"], ["FDA-1978-N-0018-1046", "FDA", "FDA-1978-N-0018", "Reference 205 - Ross_2004_Insect repellant interactions- sunscreens enhance DEET absorption", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:40:48Z", null, 0, 0, "09000064839b30de"], ["FDA-1978-N-0018-1044", "FDA", "FDA-1978-N-0018", "Reference 203 - Kaldor_1993_Non-melanoma skin cancer- 10 years of cancer registry based surveillance", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:39:03Z", null, 0, 0, "09000064839b32da"], ["FDA-1978-N-0018-1054", "FDA", "FDA-1978-N-0018", "Letter from FDA CDER to Bare Escentuals Beauty, Inc.", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T17:59:20Z", null, 0, 0, "0900006483ab2050"], ["FDA-1978-N-0018-1040", "FDA", "FDA-1978-N-0018", "Reference 199 - EPA_OPP_Labeling Review Manual_Ch3 General Labeling Requirements", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:32:04Z", null, 0, 0, "09000064839b30b3"], ["FDA-1978-N-0018-1033", "FDA", "FDA-1978-N-0018", "Reference 192 - EPA_RED Facts_DEET", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:25:34Z", null, 0, 0, "09000064839b30ac"], ["FDA-1978-N-0018-1036", "FDA", "FDA-1978-N-0018", "Reference 195 - EPA_Fact Sheet IR3535", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:27:53Z", null, 0, 0, "09000064839b30af"], ["FDA-1978-N-0018-1043", "FDA", "FDA-1978-N-0018", "Reference 202 - EPA_DEET", "Supporting & Related Material", "Background Material", "2019-02-28T05:00:00Z", 2019, 2, null, null, "2019-02-28T15:38:24Z", null, 0, 0, "09000064839b32d9"], ["FDA-1978-N-0018-1021", "FDA", "FDA-1978-N-0018", "Reference 180 - TGA_2016_Australian regulatory guidelines for sunscreens", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T21:36:08Z", null, 0, 0, "09000064839b3017"], ["FDA-1978-N-0018-0989", "FDA", "FDA-1978-N-0018", "Reference 148 - Stuart_1984_Deposition and Clearance of Inhaled Particles", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T20:36:51Z", null, 0, 0, "09000064839b314c"], ["FDA-1978-N-0018-1010", "FDA", "FDA-1978-N-0018", "Reference 169 - Damian_2011_An action spectrum for UV radiation-induced immunosuppression in humans", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T21:21:45Z", null, 0, 0, "09000064839b2fbd"], ["FDA-1978-N-0018-0994", "FDA", "FDA-1978-N-0018", "Reference 153 - Liu_2017_Particle Size Distribution Analysis of OTC Drug Products with Unintended Inhalation Exposure to Consumers", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T20:51:34Z", null, 0, 0, "09000064839b317e"], ["FDA-1978-N-0018-0975", "FDA", "FDA-1978-N-0018", "Reference 134 - Rodriguez_2006_Causal agents of photoallergic contact dermatitis", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T18:21:02Z", null, 0, 0, "09000064839b312d"], ["FDA-1978-N-0018-0939", "FDA", "FDA-1978-N-0018", "Reference 99 - Gupta_1999_Percutaneous Absorption of Sunscreens through Micro-Yucatan Pig Skin in Vitro", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T15:45:40Z", null, 0, 0, "09000064839b2f5c"], ["FDA-1978-N-0018-0943", "FDA", "FDA-1978-N-0018", "Reference 103 - Walters_1998_In Vitro Skin Permeation Evaluation- The Only Realistic Option", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T15:51:46Z", null, 0, 0, "09000064839b2cfe"], ["FDA-1978-N-0018-0928", "FDA", "FDA-1978-N-0018", "Reference 88 - Schlumpf_2001_In Vitro and in Vivo Estrogenicity of UV Screens", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T15:11:47Z", null, 0, 0, "09000064839b2cdc"], ["FDA-1978-N-0018-1029", "FDA", "FDA-1978-N-0018", "Reference 188 - NPIC_Insect Repellent Locator", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T21:56:40Z", null, 0, 0, "09000064839b301f"], ["FDA-1978-N-0018-0970", "FDA", "FDA-1978-N-0018", "Reference 129 - Dromgoole_1990_Sunscreening agent intolerance", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T17:55:39Z", null, 0, 0, "09000064839b2f72"], ["FDA-1978-N-0018-0963", "FDA", "FDA-1978-N-0018", "Reference 123 - NTP_Nomination Summary for 2-Hydroxy-4-methoxybenzophenone (N79456)", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T17:47:08Z", null, 0, 0, "09000064839b2f6c"], ["FDA-1978-N-0018-0967", "FDA", "FDA-1978-N-0018", "Reference 127 - Bruynzeel_2004_Photopatch testing- a consensus methodology for Europe", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T17:50:48Z", null, 0, 0, "09000064839b2f70"], ["FDA-1978-N-0018-0990", "FDA", "FDA-1978-N-0018", "Reference 149 - Leikauf_2013_Toxic Responses of the Respiratory System", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T20:47:44Z", null, 0, 0, "09000064839b314d"], ["FDA-1978-N-0018-0991", "FDA", "FDA-1978-N-0018", "Reference 150 - Rothe_2011_Special Aspects of Cosmetic Spray Safety Evaluations- Principles on Inhalation Risk Assessment", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T20:49:28Z", null, 0, 0, "09000064839b317b"], ["FDA-1978-N-0018-0986", "FDA", "FDA-1978-N-0018", "Reference 145 - Ng_2010_Validation of a Static Franz Diffusion Cell System for In Vitro Permeation Studies", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T20:34:10Z", null, 0, 0, "09000064839b3149"], ["FDA-1978-N-0018-0950", "FDA", "FDA-1978-N-0018", "Reference 110 - Palm_2007_Update on photoprotection", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T17:00:38Z", null, 0, 0, "09000064839b310d"], ["FDA-1978-N-0018-0946", "FDA", "FDA-1978-N-0018", "Reference 106 - Potard_2000_The Stripping Technique- In Vitro Absorption and Penetration of Five UV Filters on Excised Fresh Human Skin", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T16:49:53Z", null, 0, 0, "09000064839b3101"], ["FDA-1978-N-0018-0957", "FDA", "FDA-1978-N-0018", "Reference 117 - Schlumpf_2004_Endocrine activity and developmental toxicity of cosmetic UV filters", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T17:27:41Z", null, 0, 0, "09000064839b3114"], ["FDA-1978-N-0018-0954", "FDA", "FDA-1978-N-0018", "Reference 114 - Kadry_1995_Pharmacokinetics of Benzophenone-3 after oral exposure in male rats", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T17:19:38Z", null, 0, 0, "09000064839b3111"], ["FDA-1978-N-0018-0968", "FDA", "FDA-1978-N-0018", "Reference 128 - Bryden_2006_Photopatch testing of 1155 patients- results of the UK multicentre photopatch study group", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T17:51:38Z", null, 0, 0, "09000064839b2f71"], ["FDA-1978-N-0018-0983", "FDA", "FDA-1978-N-0018", "Reference 142 - Stenberg_1985_Sunscreen Application and Its Importance for the Sun Protection Factor", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T18:40:18Z", null, 0, 0, "09000064839b3146"], ["FDA-1978-N-0018-0940", "FDA", "FDA-1978-N-0018", "Reference 100 - Hayden_2005_Sunscreen Penetration of Human Skin and Related Keratinocyte Toxicity", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T15:46:26Z", null, 0, 0, "09000064839b2cfb"], ["FDA-1978-N-0018-1015", "FDA", "FDA-1978-N-0018", "Reference 174 - Wang_2008_In vitro assessments of UVA protection by popular sunscreens available in the US", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T21:28:46Z", null, 0, 0, "09000064839b2fe2"], ["FDA-1978-N-0018-0926", "FDA", "FDA-1978-N-0018", "Reference 86 - Gomez_2007_Estrogenic Activity of Cosmetic Components in Reporter Cell Lines", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T15:10:16Z", null, 0, 0, "09000064839b2cda"], ["FDA-1978-N-0018-0934", "FDA", "FDA-1978-N-0018", "Reference 94 - Seidlova-Wuttke_2006_Comparison of Effects of Estradiol with Those of Octylmethoxycinnamate and 4MBC", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T15:31:11Z", null, 0, 0, "09000064839b2f57"], ["FDA-1978-N-0018-0929", "FDA", "FDA-1978-N-0018", "Reference 89 - SCCNFP_2001_Opinion on the Evaluation of Potentially Estrogenic Effects of UV-filters adopted by the SCCNFP", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T15:23:52Z", null, 0, 0, "09000064839b2cdd"], ["FDA-1978-N-0018-0973", "FDA", "FDA-1978-N-0018", "Reference 132 - Heurung_2014_Adverse Reactions to Sunscreen Agent", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T18:06:03Z", null, 0, 0, "09000064839b312b"], ["FDA-1978-N-0018-1026", "FDA", "FDA-1978-N-0018", "Reference 185 - Kong_2015_Assessment of Consumer Knowledge of New Sunscreen Labels", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T21:42:18Z", null, 0, 0, "09000064839b301c"], ["FDA-1978-N-0018-1020", "FDA", "FDA-1978-N-0018", "Reference 179 - Fourtanier_2008_Sunscreens containing the BS UVA absorber prevent cutaneous detrimental effects of UV exposure", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T21:35:18Z", null, 0, 0, "09000064839b2fe7"], ["FDA-1978-N-0018-1004", "FDA", "FDA-1978-N-0018", "Reference 154 - Liu_2018_Particle Size Distribution Analysis of OTC Aerosol or Powder Drug Products with Potential for Inhalation Exposure", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T21:09:28Z", null, 0, 0, "09000064839b317f"], ["FDA-1978-N-0018-0993", "FDA", "FDA-1978-N-0018", "Reference 152 - Brown_2013_Thoracic and Respirable Particle Definitions for Human Health Risk Assessment", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T20:50:50Z", null, 0, 0, "09000064839b317d"], ["FDA-1978-N-0018-0942", "FDA", "FDA-1978-N-0018", "Reference 102 - Jiang_1996_Percutaneous Absorption of Sunscreen Agents from Liquid Paraffin", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T15:50:33Z", null, 0, 0, "09000064839b2cfd"], ["FDA-1978-N-0018-0949", "FDA", "FDA-1978-N-0018", "Reference 109 - Burnett_2011_Current sunscreen controversies", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T16:59:49Z", null, 0, 0, "09000064839b3104"], ["FDA-1978-N-0018-1016", "FDA", "FDA-1978-N-0018", "Reference 175 - Diffey_2001_Sunscreens and UVA Protection- A Major Issue of Minor Importance", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T21:30:29Z", null, 0, 0, "09000064839b2fe3"], ["FDA-1978-N-0018-1017", "FDA", "FDA-1978-N-0018", "Reference 176 - Ulrich_2009_Prevention of NMSC in organ transplant patients by regular use of a sunscreen", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T21:32:00Z", null, 0, 0, "09000064839b2fe4"], ["FDA-1978-N-0018-1024", "FDA", "FDA-1978-N-0018", "Reference 183 - Xu_2016_Sunscreen Product Performance and Other Determinants of Consumer Preferences", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T21:39:27Z", null, 0, 0, "09000064839b301a"], ["FDA-1978-N-0018-1025", "FDA", "FDA-1978-N-0018", "Reference 184 - Chao_2017_Identifying gaps in consumer knowledge about sunscreen", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T21:40:55Z", null, 0, 0, "09000064839b301b"], ["FDA-1978-N-0018-1005", "FDA", "FDA-1978-N-0018", "Reference 164 - Krauthammer_2012_Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T21:16:42Z", null, 0, 0, "09000064839b2fb8"], ["FDA-1978-N-0018-0941", "FDA", "FDA-1978-N-0018", "Reference 101 - Treffel_1996_Skin Penetration and Sun Protection Factor of Ultra-Violet Filters from Two Vehicles", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T15:48:00Z", null, 0, 0, "09000064839b2cfc"], ["FDA-1978-N-0018-0966", "FDA", "FDA-1978-N-0018", "Reference 126 - Ang_1998_Sunscreen allergy in Singapore", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T17:49:58Z", null, 0, 0, "09000064839b2f6f"], ["FDA-1978-N-0018-0965", "FDA", "FDA-1978-N-0018", "Reference 125 - Warshaw_2013_Patch Test Reactions Associated With Sunscreen Products and the Importance of Testing to an Expanded Series", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T17:49:03Z", null, 0, 0, "09000064839b2f6e"], ["FDA-1978-N-0018-0960", "FDA", "FDA-1978-N-0018", "Reference 120 - Janjua_2007_Sunscreens and thyroid function in humans after short-term whole body topical application", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T17:41:33Z", null, 0, 0, "09000064839b2f69"], ["FDA-1978-N-0018-0959", "FDA", "FDA-1978-N-0018", "Reference 119 - Nakamura_2015_Effects of maternal and lactational exposure to 2-hydroxy-4-methoxybenzone", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T17:39:45Z", null, 0, 0, "09000064839b3116"], ["FDA-1978-N-0018-1002", "FDA", "FDA-1978-N-0018", "Reference 162 - Brash_2016_UV-induced melanin chemiexcitation- a new mode of melanoma pathogenesis", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T21:06:33Z", null, 0, 0, "09000064839b2fb6"], ["FDA-1978-N-0018-0951", "FDA", "FDA-1978-N-0018", "Reference 111 - SCCP_2008_Opinion on Benzophenone-3", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T17:09:30Z", null, 0, 0, "09000064839b310e"], ["FDA-1978-N-0018-0955", "FDA", "FDA-1978-N-0018", "Reference 115 - Calafat_2008_Concentrations of the Sunscreen Agent Benzophenone-3 in Residents of the US", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T17:23:15Z", null, 0, 0, "09000064839b3112"], ["FDA-1978-N-0018-0932", "FDA", "FDA-1978-N-0018", "Reference 92 - Krause_2012_Sunscreens- are they beneficial for health", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T15:29:16Z", null, 0, 0, "09000064839b2f55"], ["FDA-1978-N-0018-0927", "FDA", "FDA-1978-N-0018", "Reference 87 - Schreurs_2002_Estrogenic Activity of UV Filters Determined by an in Vitro Reporter Gene Assay", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T15:10:57Z", null, 0, 0, "09000064839b2cdb"], ["FDA-1978-N-0018-0961", "FDA", "FDA-1978-N-0018", "Reference 121 - Schiffer_2014_Direct action of endocrine disrupting chemicals on human sperm", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T17:43:33Z", null, 0, 0, "09000064839b2f6a"], ["FDA-1978-N-0018-0979", "FDA", "FDA-1978-N-0018", "Reference 138 - Ceresole_2013_Drug-excipient compatibility studies in binary mixtures of avobenzone", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T18:34:54Z", null, 0, 0, "09000064839b3131"], ["FDA-1978-N-0018-0933", "FDA", "FDA-1978-N-0018", "Reference 93 - Szwarcfarb_2008_Octyl-Methoxycinnamate, a UV Filter, Alters LHRH and Amino Acid Neurotransmitter Release", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T15:30:19Z", null, 0, 0, "09000064839b2f56"], ["FDA-1978-N-0018-0947", "FDA", "FDA-1978-N-0018", "Reference 107 - Kurul_2001_Skin Permeation of Two Different Benzophenone Derivatives from Various Vehicles", "Supporting & Related Material", "Background Material", "2019-02-27T05:00:00Z", 2019, 2, null, null, "2019-02-27T16:53:03Z", null, 0, 0, "09000064839b3102"]], "truncated": false, "filtered_table_rows_count": 238, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-1978-N-0018", "p1": "2019"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019", "results": [{"value": "FDA", "label": "FDA", "count": 238, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 214, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 21, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019", "results": [{"value": 2019, "label": 2019, "count": 238, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&_facet=comment_end_date"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&_facet_date=last_modified"}], "next": "2019-02-27T05~3A00~3A00Z,FDA-1978-N-0018-0947", "next_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1978-N-0018&posted_year=2019&_next=2019-02-27T05~3A00~3A00Z%2CFDA-1978-N-0018-0947&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1975.8108370006084, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}